FDA Restricts Gene Therapy Skysona Due to Blood Cancer Risk

(Medage today) – The FDA approved the marking changes for Elivaldoogen Autotemcel (Eli -Cel; Skysona), punctual gene therapy for patients with adrenoleuukodystrophy Active Early (CALD), to reflect new safety information …